(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
CAS: 86639-62-5
Ref. 3D-LDA63962
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar |
Informação sobre produto
- 9-Nitrocamptothecin (Rubitecan)
4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline (EHNQ) is a potent antitumor agent that inhibits the growth of solid tumours by inducing apoptosis. EHNQ induces apoptosis through a caspase dependent pathway and triggers DNA damage. This drug has been shown to have potent anti-tumor activity in both bone cancer and subcutaneous tumors in mice. This compound also showed an increased antitumor response when used in combination with other chemotherapy drugs such as mitomycin C and vincristine sulfate. EHNQ has been shown to cause histological changes in the liver of animals treated with higher doses, but no such effects were observed at lower doses.
Propriedades químicas
Consulta técnica sobre: 3D-LDA63962 (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.